Liraglutide in Children and Adolescents with Type 2 Diabetes

Volume: 381, Issue: 7, Pages: 637 - 646
Published: Aug 15, 2019
Abstract
Metformin is the regulatory-approved treatment of choice for most youth with type 2 diabetes early in the disease. However, early loss of glycemic control has been observed with metformin monotherapy. Whether liraglutide added to metformin (with or without basal insulin treatment) is safe and effective in youth with type 2 diabetes is unknown.Patients who were 10 to less than 17 years of age were randomly assigned, in a 1:1 ratio, to receive...
Paper Details
Title
Liraglutide in Children and Adolescents with Type 2 Diabetes
Published Date
Aug 15, 2019
Volume
381
Issue
7
Pages
637 - 646
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.